Figure 3.
ADCC and CDC.51Cr-labeled NHL cells were incubated in the absence of an mAb, with the negative control mAb labetuzumab, hLL1, or rituximab in the presence of human complement (A) or human peripheral blood mononuclear cells (B), as described in “Materials and methods.” Percentage specific lysis of 3 cell lines is shown. Error bars represent SD.
